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Abstract 
The aim of the present study was to evaluate a possible interference of c~-lipoic acid (LA) or its reduced form (dithiol dihydrolipoic 
acid = DHLA) in the cardiac ischemia/reperfusion injury both at the level of the intact organ and at the subcellular level of mitochondria. 
In order to follow the effect of LA on the ischemia/reperfusion njury of the heart the isolated perfused organ was subjected to total 
global ischemia nd reperfusion i the presence and absence of different concentrations of LA. Treatment with 0.5 ~zM LA improved the 
recovery of hemodynamic parameters; electrophysiological p rameters were not influenced. However, application of 10 /xM LA to rat 
hearts further impaired the recovery of hemodynamic functions and prolonged the duration of severe rhythm disturbances in comparison 
to reperfusion of control hearts. Treatment of isolated mitochondria with any concentration f DHLA could not prevent the impairment of 
respiratory-linked nergy conservation caused by the exposure of mitochondria to 'reperfusion' conditions. However, DHLA was 
effective in decreasing the formation and the existence of mitochondrial superoxide radicals (O~-). Apart from !ts direct Oz--scavenging 
activities DHLA was also found to control mitochondrial O2- formation indirectly by regulating redox-cycling ubiquinone. It is 
suggested that impairment of this mitochondrial O2- generator mitigates postischemic oxidative stress which in turn reduces damage to 
hemodynamic heart function. 
Keywords: Heart; Mitochondria; Dihydrolipoic acid; a-Lipoic acid; Superoxide radical; Ubisemiquinone 
1. Introduction 
lschemia/reperfusion f the heart is assumed to cause 
an unphysiological production of oxygen-free radicals re- 
sulting in myocardial stunning, ventricular arrhythmias and 
a great variety of biochemical alterations [1-6]. Sulfhydryl 
groups are highly sensitive to oxygen radicals and other 
prooxidants. The maintenance of the physiological thiol 
redox status is a prerequisite to ensure the function of a 
great variety of enzymes and carrier proteins. Efforts to 
control a fall of thiol tissue levels were therefore assumed 
to be effective in the reduction or even prevention of organ 
Abbreviations: DHLA, dihydrolipoic acid; LA, a-lipoic acid; O~ , 
superoxide radical; BSA, bovine serum albumin; RHM, rat heart mito- 
chondria; P/O, ATP/oxygen ratio; RC, respiratory control index; UQ0, 
2,3-dimethoxy-5-methyl-l,4-benzoquinone; UQ, ubiquinone; UQH 2, 
ubiquinol; SQ- ,  ubisemiquinone radical. 
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damage resulting from ischemia/reperfusion. Lipoic acid 
(LA) a co-factor of mitochondrial dehydrogenase com- 
plexes was increasingly reported to aave antioxidant prop- 
erties. Its reduced form, the dithiol dihydrolipoic acid 
(DHLA), which is in equilibrium with tissue LA was 
shown to be an effective scavenger of water- and lipid- 
soluble radicals [7]. Furthermore, this compound is also 
discussed to exert stabilizing effects on the cellular thiol 
redox status [8,9]. The aim of the present study was to 
clarify the following questions: 
1. Can a-l ipoic acid/dihydrolipo:{c acid reduce myocar- 
dial ischemia/reperfusion injury when acutely adminis- 
tered before ischemia to isolated hearts? 
2. Is the a-l ipoic acid/dihydrol ipoic a id couple able to 
prevent hazardous reperfusion-induced alterations of heart 
mitochondria involved in the establishment of oxidative 
stress and energy depletion? 
3. What is the mechanism by which DHLA/LA  may 
possibly protect the heart from ischemia/reperfusion in-
jury? 
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2. Material and methods 
2.1. Chemicals 
Bovine serum albumin (fraction V, BSA), fumaric acid, 
xanthine, xanthine oxidase, L-epinephrine, 5,5'-dithiobis- 
(2-nitrobenzoic acid) and 2,3-dimethoxy-5-methyl-l,4- 
benzoquinone (UQ 0) were purchased from Sigma Chemi- 
cal (St. Louis, USA). NADH and ADP were from 
Boehringer (Mannheim, Germany), triethanolamine was 
obtained from Fluka (Buchs, Switzerland). Dihydrolipoic 
acid and c~-lipoic acid were a gift from ASTA Medica AG 
(Frankfurt, Germany). All other chemicals and biochemi- 
cals were purchased from Merck (Darmstadt, Germany). 
parameters at the end of the reperfusion period were 
related to this value. 
After a washout and equilibration period of 15 min 
hearts were perfused for 20 min to measure the preis- 
chemic control values. Then the hearts were subjected to 
30 rain of total global ischemia (37 ° C) by closing the 
aortic influx and then reperfused for 30 rain by restorating 
the flow again. Control group was perfused with Krebs- 
Henseleit medium as usual while test groups were perfused 
with perfusion medium containing different concentrations 
of ce-lipoic acid 15 min prior to ischemia and during 
reperfusion. 
2.4. Heart mitochondria 
2.2. Heart perfusion 
Male Sprague-Dawley rats (300-350 g) were anaes- 
thetized with ether and heparinized intravenously with 500 
U/kg  body weight. The hearts were rapidly removed and 
plunged into ice-cold perfusion medium until contractions 
have ceased. The heart was then cannulated via the aorta 
and perfused in the Langendorff mode [10] at a constant 
perfusion pressure of 70 mm Hg (9.33 kPa) at 37 ° C in a 
perfusion apparatus obtained from Hugo Sachs Electronic 
(March, Germany). After cannulation of the aorta, an 
incision was made in the pulmonary artery to ensure 
unhindered ejection of the coronary effluent. The perfusion 
medium was a Krebs-Henseleit buffer consisting of 118 
mM NaC1, 5.8 mM KCI, 1.2 mM MgC12, 2.5 mM CaCI 2, 
25 mM NaHCO 3, 1.2 mM NaH2PO 4 and 11 mM glucose. 
Before use, all solutions were filtered through a 0.2-/~m- 
pore filter to remove any particulate contaminants. The 
perfusate was equilibrated with a 95% 02/5% CO 2 gas 
mixture to adjust pH 7.4 at 37 ° C. 
2.3. Functional parameters, ischemia, reperfusion 
To measure the hemodynamic heart parameters a latex 
balloon was inserted into the left ventricle and inflated to a 
preload of 0.4 kPa. The left ventricular developed pressure, 
enddiastolic pressure, contractility and relaxation parame- 
ters were registered uring the hole experiment with a 
ISOTEC pressure transducer connected to a Hugo Sachs 
Electronic PLUGSYS unit (March, Germany) and recorded 
on a multi-channel ectrocardiograph (ZwiSnitz, Germany). 
Coronary flow was determined with a precalibrated flow 
meter from Hugo Sachs Electronic. The epicardial electro- 
gram was registered in order to determine heart rate, 
duration and type of arrhythmias such as ventricular tachy- 
cardia and fibrillation. The definition of arrhythmias was 
performed according to the Lambeth conventions [11]. 
Rate pressure product was calculated out of the heart rate 
and the developed pressure. For the estimation of the 
procentual recovery of the hemodynamic parameters the 
preischemic ontrol values were set as 100% and the 
Rat heart mitochondria (RHM) were isolated as de- 
scribed in [12]. The isolation buffer contained 0.3 M 
sucrose, 20 mM triethanolamine and 1 mM EDTA (pH 
7.4). ATP/oxygen ratios (P/O)  and respiratory control 
values (RC) were determined in the isolation buffer sup- 
plemented with 0.5 g BSA/I  at 25°C with a micro Clark- 
type electrode of own design. Mitochondrial protein con- 
tent was measured by the biuret method. 
State IV respiration conditions were induced by the 
addition of 5 mM glutamate plus 5 mM malate. The 
transition to state III respiration was induced by the addi- 
tion of 208 /~M ADP and 2.5 mM inorganic phosphate. 
2.5. Superoxide radical (0~ ) formation 
The Of  production was measured with a Shimadzu 
3000 UV-VIS spectrometer in a dual wavelength mode 
(480 nm/575 nm) using the SOD-sensitive pinephrine 
co-oxidation to adrenochrome. The reaction buffer con- 
sisted of 125 mM KC1, 2 mM EDTA, 20 mM tri- 
ethanolamine, 725 U catalase/ml and 0.5 mM epinephrine 
and was saturated with pure oxygen. As a standard 02 
generating system 1 mM xanthine plus 3.3 /zg/ml xan- 
thine oxidase were used. 
2.6. ESR measurements 
Ubisemiquinone (SQ- )  populations in RHM estab- 
lished under control and 'ischemia' conditions were deter- 
mined from ESR spectra of these compounds, using a 
Bruker ER 200 D-SRC spectrometer. 100 /zl of RHM 
were preincubated with NADH in the presence and ab- 
sence of DHLA. The suspension was equilibrated with 
100% O 2 or 100% N2, respectively, in order to establish 
aerobic or anaerobic onditions. The final volume (200 /xl) 
was adjusted by the addition of adequate amounts of the 
reaction buffer. Respiration was initiated upon the addition 
of 20 mM succinate plus 4 mM fumarate. In the case of 
'ischemia' (100% N 2) K3[Fe(CN) 6] (20 mM) was added 
to the suspension as an artificial e-  acceptor to keep the 
ubiquinone cycle running. The final suspension was filled 
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up into an ESR quartz tube (diameter: 3 mm) and immedi- 
ately frozen in liquid nitrogen. ESR measurements were 
carried out at 200 K using a flow dewar and a temperature 
control unit. The spectrometer settings were: microwave 
frequency 9.43 GHz, power 1 mW, modulation frequency 
100 kHz, modulation amplitude 4 G, receiver gain 4 - l0 s, 
points 1024, time constant 0.655 s, scans 4, sweep 80 G, 
centre field 3360 G, scan rate 57.2 G/min .  
3. Results 
In order to study the effect of c~-lipoic acid on the 
myocardial reperfusion injury, isolated Langendorff per- 
fused rat hearts were subjected to ischemia and reperfusion 
in the presence and absence of LA. Pretreatment of iso- 
lated hearts with 0.5 /xM LA improved significantly the 
postischemic recovery of left ventricular developed pres- 
sure (Fig. 1C), contractility (Fig. 1D), relaxation (Fig. IF) 
and the cardiac work parameters (Fig. 1B). The protective 
effect of LA was concentration-dependent. The optimal 
recovery was obtained with LA values around 0.5 /xM in 
the perfusion medium while higher LA concentrations 
caused more intensive reperfusion injuries as seen in the 
controls (=  postischemic reperfusion without LA). Elec- 
trophysiological parameters uch as the duration of sinus 
rhythm (Fig. 2A) and ventricular fibrillation (Fig. 2B) 
remained unchanged in the presence of LA concentrations 
otherwise found to improve hemodynamic functions. 
Higher LA concentrations even impaired these electro- 
physiological activities exhibiting ~ similar response as 
shown before with respect to hemodynamic parameters 
(Fig. 1 and 2). 
Since LA is metabolically reduced in the tissue to 
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Fig. 1. Postischemic recovery of hemodynamic parameters of isolated perfused rat hearts ubjected to30 min of total global ischemia treated with different 
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DHLA [13] all experiments with mitochondria were per- 
formed with DHLA. Mitochondria re equipped with the 
respective set of enzymes which establish an equilibrium 
between the oxidized and reduced form [9]. Thus, LA 
administered to the perfusion medium is readily trans- 
formed to DHLA in mitochondria. 
To evaluate whether the protective effect of LA (DHLA) 
on hemodynamic heart parameters was related to a sup- 
pression of prooxidant induced heart injury we studied 
whether DHLA will interact with O2-radical release from 
heart mitochondria. Heart mitochondria are unequivocally 
considered to be the major O2- source responsible for the 
establishment of oxidative stress following reperfusion of 
ischemic hearts [14,15]. Isolation of mitochondria from an 
ischemic/reperfused tissue causes many artifacts. There- 
fore, a model system was used where the reperfusion 
injury was simulated by an exposure of isolated RHM to 
conditions normally developed in the tissue during is- 
chemia/reperfusion. Recent studies revealed that among 
the various metabolic changes increased NADH levels 
(caused by anaerobic glycolysis) play a major role in the 
onset of oxidative stress [14]. Heart mitochondria were 
shown to have an organo-specific exogenous NADH dehy- 
drogenase [16]. Activation of this mitochondrial enzyme 
over normal is responsible of functional changes of mito- 
chondria during ischemia/reperfusion [14]. Apart from 
O2 release which accompanies mitochondrial respiration 
activation of the exogenous NADH dehydrogenase by high 
NADH concentrations also impaired respiratory control 
values (Fig. 3A) and decreased ATP production with com- 
plex I substrates (Fig. 3B). Incubation of RHM with 
DHLA (from 1 to 40 nmol DHLA/mg protein) could not 
prevent the impairment of these respiratory parameters 
caused by NADH pretreatment. 
However, DHLA caused a remarkable decrease of mito- 
chondrial O2 production. Fig. 4A shows that preincuba- 
tion of RHM with NADH induced a significantly higher 
O2 production rate (with succinate as respiratory sub- 
strate) as compared to untreated control RHM under other- 
wise identical conditions. When RHM were pretreated 
with DHLA before NADH exposure a dose-dependent 
reduction of O 2- generation was observed. In order to 
study whether the reduction of mitochondrial O~- radical 
release was due to O2 scavenging activities of DHLA the 
effect of the latter compound on the O2- generating 
xanthine/xanthine oxidase couple was studied. O) for- 
mation rates from this biochemical source were adjusted 
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quantitatively to 02- rates released from NADH-pre- 
treated RHM (Fig. 4A, B). According to our observation at 
NADH-treated RHM the existence of free O~- could be 
totally suppressed in the presence of sufficient amounts of 
DHLA. 
A DHLA-induced inhibition of xanthine oxidase activi- 
ties could be ruled out as a cause for the lack of detectable 
amounts of O2- radicals. This became evident from the 
uninhibited formation of urate which also evolves from 
xanthine oxidase-catalyzed oxidation of xanthine (exp. not 
shown). Comparison of DHLA effects on the mitochon- 
drial and the xanthine/xanthine oxidase system revealed 
that the total suppression of O2- formation was twice as 
effective in RHM as in the xanthine/xanthine oxidase 
couple. This becomes visible when 02 - formation rates 
were plotted versus DHLA concentrations (Fig. 5). 
Therefore, an additional mechanism affecting the mito- 
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Fig. 5. Comparison between the influence of DHLA on the mitochondrial 
O2- production and O2- formation in the xantbine oxidase/xanthine 
system. O2- production without DHLA was set as 100%. Experimental 
conditions: see Fig. 4. 
chondrial 02- release had to be taken into consideration. 
Due to the capability of DHLA to penetrate into phospho- 
lipid membranes a possible interference with the radical 
generating machinery of redox-cycling ubisemiquinone 
must also be considered as possible mechanism to reduce 
0 2- release. An effect of membrane-associated DHLA on 
mitochondrial steady state concentration of SQ'-  became 
evident from ESR experiments in which SQ --related ESR 
signals were followed in the absence and presence of 
DHLA (Fig. 6). DHLA was found ~.~o increase mitochon- 
drial SQ-  populations (76.0% vs. 64.4%; P < 0.01) in 
OE--generating mitochondria (NADH pretreatment). Under 
anaerobic conditions (100% N 2 instead of 100% 02) 
DHLA was without effect on mitochondrial SQ- .  
More detailed studies on this phenomenon were per- 
formed in a biochemical system in which UQ0 was dis- 
solved in water-free acetonitrile in the presence and ab- 
sence of DHLA. Interestingly the presence of DHLA (but 
not of LA) was sufficient o generate SQ-  radicals (Fig. 
7B). The reaction was associated with a consumption of 
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Fig. 6. Influence of DHLA (40 nmol/mg protein) on the ESR signal 
intensity of the ubisemiquinone radical in RHM. RHM were first exposed 
to NADH (10 mM, 25 min, at 4 ° C), for 10 nfin equilibrated with 100% 
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SH groups as demonstrated by the dithiobis method (Fig. 
7A). The disappearance of SH groups of the dithiol com- 
pound DHLA was directly related to the amount of UQ 0 
present. 
4. Discussion 
Our studies support he existence of conflicting effects 
of DHLA/LA  on the myocardial ischemia/reperfusion 
injury elsewhere reported in the literature. While some 
authors have reported on a protective action of LA or 
DHLA [13,18] others have found no effect of DHLA on 
the postischemic reperfusion i jury [19]. The present inves- 
tigation demonstrates that the effect of LA on physio- 
logical heart parameters was strongly dependent on the 
amount of LA inserted. With the exception of the coronary 
flow which was not affected all the other hemodynamic 
parameters were improved in the range of 0.5 /xM LA. 
Higher LA concentrations (10 /xM) intensified reperfusion 
injuries both on hemodynamic and electrophysiological 
heart functions. In contrast to the positive recovery effects 
of low LA concentrations on hemodynamic activities of 
reperfused hearts electrophysiological parameters showed 
no response but deterioration effects were developed as 
well at LA concentrations harmful to hemodynamic activi- 
ties. The detrimental effect of higher LA concentrations 
which affected all physiological heart functions suggests 
that beneficial and harmful activities of LA are caused by 
different mechanisms. 
The LA-related improvement of hemodynamic heart 
parameters cannot be explained on the basis of a more 
efficient energy supply in the form of ATP. In contrast o 
Zimmer et al. [8] we were unable to demonstrate any effect 
of LA (exp. not shown) or DHLA on mitochondrial en- 
ergy-linked respiration. The well known impairment of 
mitochondrial oxidative phosphorylation during 
ischemia/reperfusion [14,18,20] was not improved. Zim- 
mer et al. have drawn their conclusions from ATP synthase 
and ATPase studies of isolated RHM and mitoplasts. In 
their hands ATP synthase activities of mitoplasts ac- 
counted for only 20% of oxidative phosphorylation rates of 
intact mitochondria reported elsewhere by the same group 
[21 ]. Thus, it cannot be excluded that the effect of DHLA 
was studied at artificially altered mitochondrial prepara- 
tions. 
Since mitochondrial O2- release was efficiently sup- 
pressed by DHLA one may conclude (i) the impairment of 
hemodynamic activities of reperfused hearts is a conse- 
quence of oxidative stress associated with ischemia/reper- 
fusion and (ii) mitochondria represent the main site in the 
tissue where oxidative stress is established. In general 
radical scavenging activities of DHLA will also control 
radicals released from other sources. However, mito- 
chondria are unequivocally accepted to play a major role 
in the establishment of oxidative stress [14,15] and DHLA 
was shown to affect both the formation and the existence 
of O2- radicals from mitochondria. Apart from direct 
radical scavenging activity of DHLA which is analogue to 
scavenging reactions of other thiols DHLA [6,22-24] 
DHLA exerts an indirect radical scavenging effect which 
involves ubiquinol of mitochondria. As shown in our study 
DHLA together with UQ 0 gives rise to the formation of 
SQ radicals in acetonitrile or increases the SQ-  pool in 
respiring mitochondria. Oxidation of DHLA which was 
evaluated from the decrease of SH groups clearly indicated 
that reducing equivalents can be transferred from DHLA to 
UQ0 (reaction 1). This observation is supported by reports 
in the literature demonstrating a stimulation of redox-cy- 
cling of various quinones when dihydrolipoamide was 
present [25]. The detection of SQ-  in our in vitro system 
suggests the establishment of an equilibrium of all redox 
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states of UQ including UQH 2. The latter may result from a 
stepwise transfer of two e-  and protons from DHLA or the 
disproportionation reaction of two SQ-  and the subse- 
quent addition of protons from oxidized DHLA (reaction 
2). In mitochondria an effect of DHLA on SQ pools was 
only visible in the presence of oxygen. As earlier shown 
under our experimental conditions (NADH pretreatment as
a model system for ischemia) redox-cycling SQ-  is be- 
coming autoxidizable ([26], reaction 3) which causes a 
decrease of SQ pools (Fig. 6). Pretreatment of mito- 
chondria with DHLA mitigates this effect such that SQ-  
pools increase (Fig. 6). According to Ref. [25] we propose 
the existence of a radical reaction between 0 2- and UQH 2 
which gives rise to the formation of SQ-  and H20 2 while 
O 2- radicals disappear (reaction 4). We have work in 
progress demonstrating the existence of this type of reac- 
tion. Such a reaction can be expected to be highly efficient 
since due to the portion of DHLA (partition coefficient 
P = 257 [24]) which favours its accumulation i the lipid 
bilayer of the inner mitochondrial membrane DHLA is 
present in high amounts at the site where 02 - are formed. 
In contrast to the xanthine/xanthine oxidase system where 
02 can only be dissipated by a direct scavenging effect of 
DHLA mitochondria provide a further potential ipophilic 
O 2 scavenger namely UQH 2 which can be readily recy- 
cled by DHLA (according to reaction 1). 
DHLA(HS - SH) + UQ --~ LA(S - S) + UQH e (1) 
UQH 2 + UQ ~- 2SQ + 2H + (2) 
(H ~ ) 
SQ +O 2 ~ UQ+O 2 - (3) 
UQH 2+O2 --*SQ +H202 (4) 
Increasing LA concentrations were found to reduce all 
beneficial effects on the postischemic recovery of heart 
functions even causing deterioration of functional parame- 
ters at higher concentrations. From the literature on the 
metabolism of LA administered it is obvious that both the 
beneficial effects of low and the deteriorative ffects of 
higher LA concentrations result from DHLA which is 
readily formed from LA in the tissue [9,13]. We believe 
that the antioxidative activity of DHLA is limited by the 
accumulation capacity of the membrane so that higher 
concentrations will lead to an enrichment of DHLA in the 
aqueous phase allowing stimulation of prooxidant activi- 
ties. Evidence of the role of this dithiol compound in 
oxygen activation was demonstrated by an enhancement of 
oxidative degradation of desoxyribose [27] and ascorbic 
acid/iron-induced lipid peroxidation [28]. In the presence 
of transition metals hydroxyl radical formation occurs 
when DHLA is added as a reductant [27,29]. Prooxidant 
effects at concentrations around 0.5 mM were also found 
to exist with other thiol-containing compounds [29]. De- 
compartmentation a d release of iron was recently re- 
ported to occur as a consequence of postischemic heart 
perfusion [30,31]. Functionally non-bound DHLA may 
supply reducing equivalents to ferric iron thereby increas- 
ing decompartmentation and running a Fenton-type reac- 
tion. Furthermore, DHLA when reacting with hydroxyl 
radicals may be transformed to thiyi or sulfonyl peroxyl 
radicals [32] which in turn may perpetuate peroxidative 
damage. 
Our data have clearly demonstrated that LA (in its 
reduced form) mitigates postischemic hemodynamic im- 
pairments; furthermore, the antioxidant activity of low 
DHLA doses reveals the involvemem of oxidative stress in 
the injury of mechanical heart functions. The concentra- 
tion-dependent transition from an efficient antioxidant to a 
stimulator of oxidative stress can only be estimated quanti- 
tatively. Our study shows that in isolated perfused hearts a 
10-fold increase of DHLA concentration required to obtain 
optimal protecting effects was detrimental. 
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